Characterization of Recombinant Adeno-Associated Viral Transduction and Safety Profiles in Cardiomyocytes

被引：6
|
作者：
Ai, Jianzhong [1 ]
He, Yong [2 ]
Zheng, Mingxia [2 ]
Wen, Yi [2 ]
Zhang, Huan [2 ]
Huang, Fangyang [2 ]
Zhu, Ye [2 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Urol, Inst Urol, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Cardiol, Guoxue Xiang 37, Chengdu 610041, Sichuan, Peoples R China
来源：
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY | 2018年 / 48卷 / 05期
基金：
国家重点研发计划; 中国国家自然科学基金;
关键词：
Adeno-associated virus; Safety profile; Gene therapy; Heart diseases; Transduction efficacy; GENE-THERAPY; RENEWAL;
D O I：
10.1159/000492510
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Background/Aims: Cardiovascular diseases (CVD) are the leading causes for human mortality. However, the effective treatment for these diseases are still lacking. Currently, gene therapy could be a potential way for efficiently treating heart diseases. The aim of our study is to analyze the transduction efficacy and safety profile of recombinant adeno associated virus (AAV) serotype 9 for cardiomyocytes in vivo and in vitro. Methods: We produced rAAV serotype 9 expressing enhanced green fluorescence protein (EGFP) driven by a cardiac troponin T (cTNT) promoter, and characterized its transduction efficiency in primary cultured cardiomyocytes in vitro, and in wild-type mouse heart tissue in vivo. Results: Our data showed that rAAV9 efficiently transduced mouse cardiomyocytes in vitro. Following intravenous injection, rAAV9 could efficiently and safely transduce cardiomyocytes that are involved in heart diseases. Conclusion: Our findings suggested that rAAV9 can efficiently and safely transduce cardiomyocytes in vitro and/or in vivo. The rAAV9 serotype vector could constitute a powerful toolbox for future gene therapy of heart diseases. (C) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码：1894 / 1900
页数：7
相关论文
共 50 条
  • [1] Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes
    Srdjan Djurovic
    Nina Iversen
    Stig Jeansson
    Frank Hoover
    Geir Christensen
    Molecular Biotechnology, 2004, 28 : 21 - 31
  • [2] Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes
    Djurovic, S
    Iversen, N
    Jeansson, S
    Hoover, F
    Christensen, G
    MOLECULAR BIOTECHNOLOGY, 2004, 28 (01) : 21 - 31
  • [3] The role of furin in recombinant adeno-associated viral vectors infection and transduction
    Suarez, L.
    Paneda, A.
    Zabaleta, V.
    Olaguee, C.
    Vales, A.
    Buning, H.
    Aldabe, R.
    Prieto, J.
    Gonzalez-Aseguinolaza, G.
    HUMAN GENE THERAPY, 2013, 24 (12) : A72 - A72
  • [4] Transduction Profiles of Engineered Adeno-Associated Viral Capsids in Mouse and Marmoset
    Goertsen, David
    Flytzanis, Nicholas C.
    Goeden, Nick
    Cummins, Alexander
    Pickel, James
    Gradinaru, Viviana
    MOLECULAR THERAPY, 2020, 28 (04) : 269 - 270
  • [5] The use of recombinant adeno-associated viral vectors for the transduction of epithelial tumor cells
    Hoerer, M
    Bogedain, C
    Scheer, U
    Heberger, C
    Steyrer, S
    Burger, A
    Maass, G
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1997, 19 (9-10): : 473 - 479
  • [6] Organoid transduction using recombinant adeno-associated viral vectors: Challenges and opportunities
    Belova, Lyubava
    Lavrov, Alexander
    Smirnikhina, Svetlana
    BIOESSAYS, 2022, 44 (09)
  • [7] Recombinant adeno-associated virus transduction and integration
    Schultz, Brian R.
    Chamberlain, Jeffrey S.
    MOLECULAR THERAPY, 2008, 16 (07) : 1189 - 1199
  • [8] Safety of recombinant adeno-associated viral vectors in a large animal model
    Favaro, Patricia
    Downey, Harre D.
    Mingozzi, Federico
    Wright, Fraser
    Hauck, Bemd
    High, Katherine A.
    Arruda, Valder R.
    BLOOD, 2007, 110 (11) : 762A - 762A
  • [9] Safety of adeno-associated viral vectors
    Lin, Shih-Wen
    Ertl, Hildegund C. J.
    FUTURE VIROLOGY, 2008, 3 (05) : 491 - 503
  • [10] Purification of Recombinant Adeno-Associated Viral Vectors
    Pan, Xing
    MOLECULAR THERAPY, 2020, 28 (04) : 538 - 538
12345